1. Academic Validation
  2. Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia

Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia

  • Nat Microbiol. 2025 Nov;10(11):2736-2748. doi: 10.1038/s41564-025-02135-z.
Vivek Hariharan 1 Jennifer A White 1 Filippo Dragoni 1 Emily J Fray 1 Nicholas Pathoulas 1 Milica Moskovljevic 1 Hao Zhang 2 Anushka Singhal 1 Jun Lai 1 Subul A Beg 1 Eileen P Scully 1 Elizabeth A Gilliams 1 David S Block 1 Jeanne Keruly 1 Richard D Moore 1 Janet D Siliciano 1 Francesco R Simonetti 3 Robert F Siliciano 4 5
Affiliations

Affiliations

  • 1 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • 2 Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • 3 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. fsimonetti@jhmi.edu.
  • 4 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. rsiliciano@jhmi.edu.
  • 5 Howard Hughes Medical Institute, Baltimore, MD, USA. rsiliciano@jhmi.edu.
Abstract

During replication of some RNA viruses, defective particles can spontaneously arise and interfere with wild-type (WT) virus replication. However, these defective interfering particles (DIPs) have not been reported in people with HIV-1 (PWH). Here we find DIPs in PWH who have a rare, polyclonal form of non-suppressible viraemia (NSV). We characterized the source of NSV in two PWH who never reached undetectable viral load despite adherence to antiretroviral therapy (ART). Remarkably, in each participant, we found a diverse set of defective viral genomes sharing the same fatal deletions. This paradoxical accumulation of mutations by viruses with fatal defects was driven by superinfection with intact viruses, resulting in mobilization of defective genomes and accumulation of additional mutations during untreated Infection. These defective proviruses interfere with WT virus replication, conditionally replicate and, in one case, have an R0 > 1, enabling in vivo spread. Despite this, clinical outcomes showed no beneficial effect of these DIPs. These findings demonstrate that fatally defective proviruses, traditionally considered evolutionary dead ends, can replicate and diversify upon superinfection without preventing disease progression.

Figures
Products